AREV logo.png
Kevin Phelps, CPA Appointed Chief Operating Officer of Arev Life Sciences Global Corporation & Warrant Offering
21 avr. 2022 17h15 HE | AREV Life Sciences Global Corp.
VANCOUVER, BC , April 21, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) AREV Life Sciences Global Corporation...
AREV logo.png
AREV Life Sciences Global Corporation announces engagement of TransBIOTech to facilitate preclinical therapeutic pipeline development
21 avr. 2022 16h52 HE | AREV Life Sciences Global Corp.
VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- via InvestorWire  -- AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) announced today its initial...
Isracann BioSciences Logo RGB@4x-100 LG.jpg
Isracann Biosciences Acquires Natural Health Medicine Developer and Appoints Natural Health Products Officers
13 avr. 2022 08h30 HE | Isracann Biosciences Inc.
VANCOUVER, British Columbia, April 13, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the...
Steven J. Durning, MD, PhD, Selected as NBME’s 2022 John P. Hubbard Award Recipient
06 avr. 2022 14h32 HE | NBME
Philadelphia, PA, April 06, 2022 (GLOBE NEWSWIRE) -- NBME congratulates Steven J. Durning, MD, PhD, as the recipient of its 2022 John P. Hubbard Award in recognition of his extensive contributions...
silo.png
IBN (InvestorBrandNetwork) Coverage Initiated for Silo Pharma Inc.
30 mars 2022 08h30 HE | Silo Pharma Inc.
NEW YORK, March 30, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – Silo Pharma Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with...
22157.jpg
Global Pharma, Biotech and Diagnostics Option and Evaluation Deals Report/Directory 2021
29 mars 2022 04h23 HE | Research and Markets
Dublin, March 29, 2022 (GLOBE NEWSWIRE) -- The "Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021" report has been added to...
Cybin LOGO.png
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Leads Out in Psychedelic-Based Therapeutics Space
07 mars 2022 08h30 HE | Cybin Inc.
NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) announces the availability of a broadcast titled, “Psychedelic Therapies Offer Hope for...
Cybin LOGO.png
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Unleashing Power of Psychedelics
03 mars 2022 08h30 HE | Cybin Inc.
NEW YORK, March 03, 2022 (GLOBE NEWSWIRE) -- via InvestorWire — Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one...
Axis Research & Technologies Opens Fourth U.S. Location
01 mars 2022 08h00 HE | Axis Research & Technologies
IRVINE, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Axis Research & Technologies, a premier bioskills training and cadaver lab supporting medical device research and training, announced the...
Microdose Psychedelics Presents a Molecular Masterclass: The LSD Conference
10 févr. 2022 09h35 HE | Microdose Psychedelic Insights
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- via PsychedelicNewsWire -- Microdose Psychedelic Insights, a cutting-edge conference production company focused on promoting content, financial analysis...